MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2021 » Other

Meeting: MDS Virtual Congress 2021

“I’ve got cataracts and can’t read the information sheet about the medication you have given me”*

P. Hobson, V. Adhiyaman (Rhyl, United Kingdom)

A Case of Autoimmune Orofacial Dyskinesia associated with Striational Antibody

K. Kyle, G. Crotty, N. Venna (Boston, USA)

ADROIT study: current recruitment and DBS implant data

S. Groppa, J. Pilitsis, S-Y. Shin-Yuan, J. Vesper, L. Verhagen, Y. Bezchlibnyk, M. Navas Garcia, K. Ashkan, S. Nagel, R. Pahwa, C. Giordana, A. Lehn, T. Warnecke, M. Glaser, S. Lin, F. Defresne, E. Karst, B. Cheeran, A. Schnitzler (Mainz, Germany)

Alpha-synuclein oligomers detection by proximity ligation assay in skin biopsy is a biomarker for Parkinson’s disease

E. Vacchi, C. Senese, S. Pinton, A. Kaelin-Lang, G. Melli (Lugano, Switzerland)

An International Pre-Implementation Survey To Assess The Acceptability Of Telemedicine As An Alternative To In-Person Clinic Consultations For PD

O. Ojo, JH. Ahn, Z. Aldaajani, J. Bajwa, A. Bustillo, A. Cardozo, M. Dekker, E. Eldayem, Z. Mari, A. Shalash, M. Shackleford, M. Spindler, J. Youn, E. Cubo, N. Okubadejo (Idi-Araba, Nigeria)

Analysis of handgrip strength, upper limb traction and ground reaction force on bus step climb in healthy elderly subjects and individuals with Parkinson’s disease

A. Miri, H. Gonçalves Araújo, A. Gil, E. Angelo, R. Volpe, B. Masson, A. da Silva, S. Smaili (Londrina, Brazil)

Botulinum toxin injections for sialorrhea in Parkinson´s disease and parkinsonism: 5 years follow up

C. Borrue, C. Jimeno (Madrid, Spain)

Data Driven Paths to Advancing Precision Medicine Strategies for Parkinson’s Disease: Critical Path for Parkinson’s Consortium

M. Muller, D. Dexter, J. Cosman, C. Zadikoff, S. Ali, N. Barwick, B. Bloem, B. Boroojerdi, J. Burton, C. Carroll, J. Cedarbaum, T. Dam, P. Dawkins, D. Grosset, N. Hanan, D. Hill, M. Hu, D. Jennings, S. Jones, K. Kieburtz, R. Lawson, K. Lee, K. Marek, H. Matthews, N. Mehrotra, J. Molinuevo, P. Muglia, A. Naito, G. Pagano, S. Sardi, M. Schwarzschild, A. Simen, T. Simuni, G. Stebbins, C. Venuto, C. Williams-Gray, D. Stephenson (Tucson, USA)

Direct Costs of patients with Parkinson’s Disease in a region of the Brazilian Amazon

R. Feio, T. França, A. Passos, A. Silva, A. Escudeiro, B. Koshimoto, D. Moura, B. Lobato (Belém, Brazil)

Disparities in Access to Spasticity Chemodenervation Specialists in the United States: a National Analysis of Medicare Data

R. Kazerooni, S. Healy, M. Verduzco-Gutierrez (Raleigh, USA)

Does Macronutrient dietary Intake of patients with Parkinson disease correlates with the cognitive function (MoCA)?

C. López Botello, S. Castillo Torres, I. Estrada Bellmann, B. Chávez Luevanos (Monterrey, Mexico)

EFFECT OF TRANSCRANIAL DIRECT CURRENT STIMULATION (tDCS) ON LOCOMOTOR FUNCTION IN PATIENTS WITH PARKINSON’S DISEASE

M. Shah, B. Bajaj, I. Ali (New Delhi, India)

Evaluating Patients’ Preferences for Parkinson’s Disease Treatments

M. Serbin, J. Sutphin, C. Leach, C. Mansfield, C. Yonan, O. Klepitskaya, M. Sheehan, A. Donnelly (San Diego, USA)

Evaluation of Care delivery model for integrated care and self-management for people with Parkinson’s disease with Deep Brain Stimulation

D. Dash, D. Cote, J. Conway, A. Basndwah, D. Grimes, T. Mestre (Ottawa, Canada)

Experiences of home-based dance participation in people with Parkinson’s

J. Bek, M. Groves, D. Leventhal, E. Poliakoff (Manchester, United Kingdom)

Facial dyskinesias mimics a new-onset status epilepticus in a patient with autoimmune encephalitis

J. Diestel Bautista, Z. Rojas Cheje, A. Michel Chavez, C. Mendoza Tejeda, D. Rebolledo García, H. Sentíes Madrid (México City, Mexico)

Facial Paralysis Associated with COVID-19: a systematic review.

B. Franco, G. Aragão, M. Pereira, I. Vasconcelos, A. Nunes, C. Filho (Salvador, Brazil)

How can patients’ trajectories inform the co-design of an integrated care network for people living with Parkinson’s Disease?

S. Grosjean, J. Farré Coma, O. Gal, A. Laffan, A. Sendra, J. Stuempel, T. Mestre (Ottawa, Canada)

Hyperkinetic Movement Disorders after Thalamic Lesions

S. Torabi, Y. Kianirad (Chicago, USA)

Identifying and Controlling Variability in Digital Health Measures in Parkinson’s disease Clinical Trials

G. Roussos, R. Bhatnagar, J. Burton, J. Cosman, A. Derungs, A. Dowling, K. Fisher, D. Hill, K. Praneeth Kilambi, L. Evers, N. Mehrotra, M. Minchik, M. Muller, T. Ruiz Herrero, S. Sardar, D. Stephenson (London, United Kingdom)

IMMUNE-MEDIATED MOVEMENT DISORDERS: CLINICAL MANIFESTATIONS, TREATMENT, AND EVOLUTION. A MULTICENTER STUDY

M. Bala, F. Gonzalez, M. Saucedo, L. Bandeo, A. Chertcoff, L. de Francesco, G. Napoli, L. Leon Cejas, P. Bonardo, N. Morera, L. Tschopp, C. Rugilo, C. Calandra, A. Pellene, G. Raina, Z. Salazar, G. Rinaldi, P. Judewicz, J. Rivas, J. Gustavo Jose, D. Ballesteros, M. Tela, F. Gualtieri, J. Amor, C. Esliman, F. Caiza Zambrano, T. Arakaki, N. Garretto, S. Rodriguez, A. Kohler, A. Laffue, O. Martinez, M. Fernandez Pardal, R. Reisin, C. Uribe Roca (Caba, Argentina)

Impact of extended quarantine during the COVID-19 pandemic on Parkinson’s disease (PD) patients.

G. Lopez, V. Kurtz, B. Charra, E. Garino, D. Ballesteros (Buenos Aires, Argentina)

Motor evaluation of Parkinson’s disease patients through video consultations in the Brazilian public health system – a real life feasibility study

D. Dos Santos, D. Camelo, M. Strelow, M. Silva, P. Führ, L. Marins, A. Schumacher-Schuh (Porto Alegre, Brazil)

Movement disorders in demyelination: A case series of ten patients

R. Singh, S. Pandey (New Delhi, India)

Movement Disorders in Subacute Sclerosing Panencephalitis Patients

C. Rawat, S. Pandey (New Delhi, India)

Neuroleptic Malignant Syndrome: Case Series of Movement Disorders Emergency

IAH. Hakim, NR. Raisa, WMS. Santoso, CAS. Setianto (Malang, Indonesia)

New-onset movement disorders in patients with COVID-19 from two centers in Western India

S. Adukia, S. Panat, M. Munshi, P. Joshi, K. Shetty, T. Singhal, M. Bhatt, A. Aggarwal (Mumbai, India)

Outcome of Movement Disorders affected by Covid-19: case series from a single Movement Disorders Unit

M. Demirkiran, G. Aktan, M. Balal (Adana, Turkey)

Parkinson’s disease and Post-COVID-19 syndrome

V. Leta, M. Rodríguez-Violante, A. Abundes, K. Rukavina, J. Teo, C. Falup-Pecurariu, L. Irincu, S. Rota, R. Bhidayasiri, A. Storch, P. Odin, A. Antonini, K. Ray Chaudhuri (London, United Kingdom)

Patterns of Improvement with Valbenazine in Patients with Tardive Dyskinesia

C. Correll, T. Carmack, C. Shah, L. Lundt (Glen Oaks, USA)

PERCEPTION OF INDIVIDUALS WITH PARKINSON´S DISEASE ABOUT ISOLATION DURING THE COVID-19 PANDEMIC

R. Pasquarelli Volpe, L. Laskovski, S. Mahmoud Smaili (Londrina, Brazil)

Precision Medicine in Neurodegeneration associated with Pantothenate kinase (PKAN) , its possible?

J. Abril Jaramillo (Seville, Spain)

Progressive encephalomyelitis with rigidity and myoclonus in a Mexican patient

R. Garcia-Bermudez, D. Leon-Castillo, B. Bertado-Cortes (Mexico City, Mexico)

PSYCHODYNAMIC THERAPY GROUPS FOR RELATIVES AND CAREGIVERS IN THE CONTEXT OF A PD PROGRAM

L. Aguerre, E. Cortinas, M. Martinovic, G. Montado (Montevideo, Uruguay)

Rapid Onset Stiff Person Syndrome

B. Neeley, G. Pawar, R. Tripathi (Morgantown, USA)

Risk of cancer in Parkinsons’s disease: a systematic review of diagnostic validity

A. Mehdiyeva, V. Kaasinen, J. Mauri, J. Sipilä (Joensuu, Finland)

Safety of MRI performed with leads-only or fully implanted DBS system

J. Wilden, C. Torres Diaz, S. Groppa, D. Gaudin, E. Hargreaves, D. Vansickle, P. Slotty, A. Gharabaghi, E. Jiltsova, S. Ojemann, J. Aldred, S. Redding, D. Weiss, F. Defresne, E. Karst, B. Cheeran, R. Gross (Shrevport, USA)

Sleep Quality and Nutrition effects in patients with Parkinson’s Disease

C. López Botello, A. Pérez Arzola, B. Chávez Luevanos, S. Castillo Torres, D. Martínez Roque, I. Estrada Bellmann (Monterrey, Mexico)

Spectrum of Movement Disorders among Children with Subacute Sclerosing Panencephalitis (SSPE): A Cross-sectional Study

D. Garg, V. Kakkar, D. Kapoor, S. Sharma, S. Mukherjee, H. Pemde (New Delhi, India)

Stiff Person Syndrome Presenting with Dystonia

F. Gao (Honolulu, USA)

Stiff-person syndrome – a 15-year review at a tertiary hospital

R. Rodrigues, L. Sousa, R. Samões, G. Cação, J. Chaves, M. Cardoso, J. Barros, E. Santos, J. Damásio (Santa Maria Feira, Portugal)

Subacute cerebellar degeneration and Holmes tremor secondary to paraneoplastic non-Hodgkin’s lymphoma

J. Frey, J. Toledo, A. Ramirez-Zamora, I. Malaty (Gainesville, USA)

Tele and video consultations of patients with parkinsonism in the Brazilian public health system – a real life feasibility study

D. Dos Santos, D. Freire Camelo, M. Strelow, M. Silva, P. Führ, L. Marins, A. Schumacher-Schuh (Porto Alegre, Brazil)

The alien hand syndrome

A. Balan, I. Buraga (Bucharest, Romania)

The Development of a Parkinson’s Disease Biomarker Inventory Dashboard

M. Pauley, K. Merchant, S. Hutten, M. Frasier, M. Lawton, D. Dexter, M. Muller, D. Stephenson (Tucson, USA)

The role of community engagement and involvement in Parkinson’s disease research: a case study from Africa

N. Fothergill-Misbah, O. Thomas, H. Mwithiga, R. Walker (Newcastle Upon Tyne, United Kingdom)

TNF-α Mediated Neuroinflammation Associated with UPRmt in Kaolin Induced Hydrocephalus Mouse Model

J. Zhu, M. Lee, Y. Jang, Y. Lee, E. Namgung, W. Chung, C. Seo, E. Oh, J. Heo (Daejeon, Republic of Korea)

« View all sessions from the MDS Virtual Congress 2021.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley